LASTACAFT ® Antihistamine Eye Drops Drug Facts

Manufacturer: Allergan, Inc.
Effective date: 2022-08-10
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 00:55:16

Label at a glance#

ProductLASTACAFT

Active ingredientalcaftadine

Label structure10 sections

Dosage and administration

a dults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use c hildren under 2 years of age : consult a doctor

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Alcaftadine 0.25%

Purpose

OTC - PURPOSE SECTION

Antihistamine

Use

INDICATIONS & USAGE SECTION

temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

■ if solution changes color or becomes cloudy

■ if you are sensitive to any ingredient in this product

■ to treat contact lens related irritation

When using this product

OTC - WHEN USING SECTION

■ do not touch tip of container to any surface to avoid contamination

■ remove contact lenses before use

■ wait at least 10 minutes before reinserting contact lenses after use

■ do not wear a contact lens if your eye is red

Stop use and ask a doctor if

OTC - STOP USE SECTION

you experience any of the following:

■ eye pain

■ changes in vision

■ increased redness of the eye

■ itching that worsens or lasts for more than 72 hours

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 2 years of age and older:
- put 1 drop in the affected eye(s) once daily
- if using other ophthalmic products while using this product, wait at least 5 minutes between each product
- replace cap after each use
children under 2 years of age: consult a doctor

Other information

OTHER SAFETY INFORMATION

■ only for use in the eye

■ store at 15°-25°C (59°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride 0.005%, edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid

Questions or comments?

OTC - QUESTIONS SECTION

telephone icon1.800.678.1605

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0023-4291-10
ORIGINAL
PRESCRIPTION STRENGTH
LASTACAFT ^®
Alcaftadine ophthalmic solution 0.25%
Antihistamine Eye Drops
ONCE DAILY RELIEF
Eye Allergy Itch Relief
WORKS IN MINUTES
RELIEF FROM ALLERGENS:
Pet Dander Pollen Grass Ragweed
STERILE
120 DAY SUPPLY
Two 5 mL bottles (0.17 fl oz each)

NDC 0023-4291-10 ORIGINAL PRESCRIPTION STRENGTH LASTACAFT® Alcaftadine ophthalmic solution 0.25% Antihistamine Eye Drops ONCE DAILY RELIEF Eye Allergy Itch Relief WORKS IN MINUT...

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0023-4291-05
ORIGINAL
PRESCRIPTION STRENGTH
LASTACAFT ^®
Alcaftadine ophthalmic solution 0.25%
Antihistamine Eye Drops
ONCE DAILY RELIEF
Eye Allergy Itch Relief
WORKS IN MINUTES
RELIEF FROM ALLERGENS:
Pet Dander Pollen Grass Ragweed
STERILE
60 DAY SUPPLY
0.17 fl oz (5 mL)

NDC 0023-4291-05 ORIGINAL PRESCRIPTION STRENGTH LASTACAFT® Alcaftadine ophthalmic solution 0.25% Antihistamine Eye Drops ONCE DAILY RELIEF Eye Allergy Itch Relief WORKS IN MINUT...

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1000085	alcaftadine 0.25 % Ophthalmic Solution	PSN	4
1000089	LASTACAFT 0.25 % Ophthalmic Solution	PSN	4
1000089	alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft]	SBD	4
1000085	alcaftadine 2.5 MG/ML Ophthalmic Solution	SCD	4
1000085	alcaftadine 0.25 % Ophthalmic Solution	SY	4
1000089	Lastacaft 0.25 % Ophthalmic Solution	SY	4
1000089	Lastacaft 2.5 MG/ML Ophthalmic Solution	SY	4

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ALCAFTADINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4b7a6bd5-956e-f134-86e5-d4d9706c15d4	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0023-4291-01	LASTACAFT	1 in 1 CARTON	SOLUTION/ DROPS	1	4
0023-4291-01	LASTACAFT	1 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	1	4
0023-4291-05	LASTACAFT	1 in 1 CARTON	SOLUTION/ DROPS	1	4
0023-4291-05	LASTACAFT	5 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	5	4
0023-4291-06	LASTACAFT	5 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	5	4
0023-4291-06	LASTACAFT	1 in 1 CARTON	SOLUTION/ DROPS	1	4
0023-4291-07	LASTACAFT	5 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	5	4
0023-4291-07	LASTACAFT	2 in 1 CARTON	SOLUTION/ DROPS	2	4
0023-4291-10	LASTACAFT	2 in 1 CARTON	SOLUTION/ DROPS	2	4
0023-4291-10	LASTACAFT	5 mL in 1 BOTTLE, PLASTIC	SOLUTION/ DROPS	5	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0023-4291	LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.]	4	Current NDC, Legacy NDC, 10 package rows	20250215_a3002410-4bf1-4182-9d7c-8193eb7cd215.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0023-4291-05	ML - Milliliter	0023-4291	58343e47-47f7-4c65-9ef9-e3d340c8e6f2	1	2022-02-07
0023-4291-10	ML - Milliliter	0023-4291	8662c004-68f5-4800-ac70-15cbb107bdef	1	2022-02-07

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

LASTACAFT
alcaftadine
BENZALKONIUM CHLORIDE
edetate disodium
sodium phosphate, monobasic
water
sodium chloride
sodium hydroxide
hydrochloric acid

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0023-4291	0023-4291-05, 0023-4291-10, 0023-4291-01, 0023-4291-06, 0023-4291-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
alcaftadine	7Z8O94ECSX	ACTIB
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
edetate disodium	7FLD91C86K	IACT
sodium phosphate, monobasic	3980JIH2SW	IACT
water	059QF0KO0R	IACT
sodium chloride	451W47IQ8X	IACT
sodium hydroxide	55X04QC32I	IACT
hydrochloric acid	QTT17582CB	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022134-001	LASTACAFT	ALCAFTADINE	0.25%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2010-07-28

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12
N022134-001	8664215	2027-12-23	U-3267		2014-03-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022134-001	LASTACAFT	0.25%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2010-07-28	`3a93d1ddd44b…`

Observed Orange Book patent history#

Patent history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-10-15 13:18:30	2026-09	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022134-001	10617695	2027-03-19	U-3267	Drug product	2020-05-12	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022134-001	8664215	2027-12-23	U-3267		2014-03-21	`4b0b4de00fa7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LASTACAFT	ALCAFTADINE	Allergan, Inc.	a3002410-4bf1-4182-9d7c-8193eb7cd215	2022-08-10	Warnings	Exact identifier ndc (package): 0023-4291-10 ndc (package): 0023-4291-07 ndc (package): 0023-4291-05 ndc (package): 0023-4291-01 ndc (package): 0023-4291-06 ndc (product): 0023-4291 ndc11 (package): 00023429105 ndc11 (package): 00023429107 ndc11 (package): 00023429101 ndc11 (package): 00023429110 ndc11 (package): 00023429106 spl id: 447257d6-c313-499e-8a48-499badb37766 spl set id: a3002410-4bf1-4182-9d7c-8193eb7cd215

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.